Myocardial Infarction in the Absence of Obstructive Epicardial Coronary Disease
We read with interest the study by Dokainish et al. (1) reporting characteristics and outcomes of patients with acute coronary syndromes in the absence of obstructive epicardial coronary disease in a post hoc analysis of the TACTICS-TIMI-18 trial. Six percent of patients presenting with an apparent acute coronary syndrome (ACS) and troponin elevation were found to have no significant epicardial disease at angiography. These patients were more likely to be female, and rates of death and reinfarction were lower in this group at six months when compared with those who had angiographically significant coronary disease, regardless of troponin elevation.
The investigators discuss potential mechanisms of myocardial infarction in patients without significant epicardial coronary disease, but they do not consider transient left ventricular apical ballooning syndrome (TLVABS) as a potential explanation in some of these patients (2) (3) (4) (5) (6) . In a recent systematic review of TLVABS, we and others have pointed out that these patients are typically postmenopausal females who present with acute-onset ischemic cardiac symptoms, electrocardiographic changes, mildly elevated cardiac biomarkers, and characteristic yet transient apical and midventricular wall motion abnormalities in the absence of obstructive epicardial coronary disease (7) . The risk of mortality associated with the syndrome appears to be low and recurrence uncommon. It may be that some of the reported patients presenting with an apparent ACS with troponin elevation in the absence of obstructive epicardial coronary disease had TLVABS, which in turn may explain the observed lower rates of mortality and reinfarction in this patient cohort.
Finally, TLVABS is underrecognized and should be considered in the differential diagnosis of patients presenting with an apparent ACS in the absence of obstructive coronary artery disease. The mechanisms responsible for TLVABS are unknown and deserve further investigation. 
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Lack of Prognostic Impact of Elevated Troponin Levels in Patients Without Coronary Artery Disease
The study by Dokainish et al. (1) addresses an interesting subgroup of patients with acute coronary syndromes (ACS), namely those with elevated troponin but without significant coronary artery disease (CAD) on angiography. The investigators conclude that a 6.3% incidence of death, reinfarction, and rehospitalization in this subgroup suggests an adverse prognosis as compared to the subgroup without significant CAD and negative troponin.
It is important to note that the figure of 6.3% is based on a total sample size of 32 patients. There were two adverse events in this group including one death and one rehospitalization. The researchers do not report whether these events were cardiovascular or not, information with clear implications for their conclusions. Even if these two events were cardiovascular, the tiny sample size severely limits the conclusions that can be drawn. It is also possible that the bias of knowledge of previous elevated troponin influenced the decision making in the single patient who was rehospitalized.
In addition, data from 
